J. Ferrières, Dyslipid??mies et risque cardiovasculaire??: donn??es ??pid??miologiques, EMC - Endocrinologie - Nutrition, vol.7, issue.4, 2010.
DOI : 10.1016/S1155-1941(10)51268-X

M. Paillasse, Métabolisme du cholestérol et cancer, thèse d?exercice, 2009.

. Pharmaetudes and . Com, Métabolisme des acides gras, des triglycérides, du cholestérol, des lipoprotéines ? dernière consultation le 01

F. Laracine, Rôle des PPAR dans le métabolisme lipidique, Thèse d?exercice, 2009.

T. Gautier, D. Masson, and L. Lagrost, M??tabolisme des lipides et des lipoprot??ines chez l'homme, Endocrinologie-Nutrition, pp.10-368, 2010.
DOI : 10.1016/S1155-1941(10)51260-5

J. Léoni, Physiopathologie de l'athérosclérose ? Mécanismes et prévention de l'athérothrombose, thèse d?exercice, 2011.

M. Schorderet, Pharmacologie des concepts fondamentaux aux applications thérapeutiques. Edition Frisson-Roche, 1998.

J. G. Hardman and L. E. Limbird, Mc Graw-Hill. Les bases pharmacologiques de l'utilisation des médicaments 9 ème Edition. International Ltd, 1998.

H. Peter and . Langsjoen, Introduction to Coenzyme Q10, 1994.

G. Cragg, M. Levine, J. Moss, and P. White, Encyclopedia of Dietary Supplements, pp.121-131

L. Ernster, Lipid peroxidation in biological membranes: Mechaninsm and implications. In: Active Oxygens, Lipid Peroxides, and Antioxidants, 1993.

T. Yamagami, M. Takagi, and H. Akagami, Effect of coenzyme Q10 on essential hypertension, a double-blind controlled study, Biomedical and Clinical Aspects of Coenzyme Q10: Proceedings of the Fifth International Symposium on the Biomedical and Clinical Aspects of Coenzyme Q10, pp.337-343, 1986.

C. Weber, Dietary Intake and Absorption of Coenzyme Q, Coenzyme Q: Molecular Mechanisms in Health and Disease. Boca Raton, pp.209-215
DOI : 10.1201/9781420036701.ch13

V. Schulz, R. Hänsel, and V. Tyler, Rational Phytotherapy -A Physicians' Guide to Herbal Medicine, p.155, 2001.

F. Aberg, E. Appelkvist, . Dallner, and . Ernster, Distribution and redox state of ubiquinones in rat and human tissues, Archives of Biochemistry and Biophysics, vol.295, issue.2, pp.230-234, 1992.
DOI : 10.1016/0003-9861(92)90511-T

G. H. Addona, M. Sandermann-jr, S. Kloczewiak, . Husain, and . Miller, Where does cholesterol act during activation of the nicotinic acetylcholine receptor?, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1370, issue.2, pp.299-309, 1998.
DOI : 10.1016/S0005-2736(97)00280-0

J. Aittoniemi, T. Róg, P. Niemelä, M. Pasenkiewicz-gierula, M. Karttunen et al., Tilt:?? Major Factor in Sterols' Ordering Capability in Membranes, The Journal of Physical Chemistry B, vol.110, issue.51, 2006.
DOI : 10.1021/jp064931u

C. M. Ballantyne, A. Corsini, H. Michael, H. Davidson, . Holdaas et al., Risk for Myopathy With Statin Therapy in High-Risk Patients, Archives of Internal Medicine, vol.163, issue.5, pp.553-564, 2003.
DOI : 10.1001/archinte.163.5.553

R. S. Belo, J. Jamieson, and . Wright, Studies on the effect of mevinolin (lovastatin) and mevastatin (compactin) on the fusion of L6 myoblasts, Molecular and Cellular Biochemistry, vol.113, issue.2, pp.159-167
DOI : 10.1007/BF00925694

M. Bentinger, M. Tekle, and G. Dallner, Coenzyme Q ??? Biosynthesis and functions, Biochemical and Biophysical Research Communications, vol.396, issue.1, 2010.
DOI : 10.1016/j.bbrc.2010.02.147

M. Bentinger, M. Turunen, X. Zhang, Y. Wan, and G. Dallner, Involvement of Retinoid X Receptor ?? in Coenzyme Q Metabolism, Involvement of Retinoid X Receptor Alpha in Coenzyme Q Metabolism, pp.795-803, 2003.
DOI : 10.1016/S0022-2836(02)01447-X

R. Bentley, The Shikimate Pathway ??? A Metabolic Tree with Many Branche, Critical Reviews in Biochemistry and Molecular Biology, vol.381, issue.5, pp.10-3109, 1990.
DOI : 10.1016/0031-9422(89)85065-4

R. E. Beyer, J. Segura-aguilar, D. Bernardo, . Cavazzoni, . Fato et al., The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems., Proceedings of the National Academy of Sciences of the United States of America 93, pp.2528-2532, 1996.
DOI : 10.1073/pnas.93.6.2528

M. Björnstedt, T. Nordman, M. Et-jerker, and . Olsson, Extramitochondrial Reduction of Ubiquinone by Flavoenzymes, Methods in Enzymology, vol.378, issue.04, pp.10-1016, 2004.
DOI : 10.1016/S0076-6879(04)78008-8

D. A. Bookstaver, A. Nancy, C. Burkhalter, and . Hatzigeorgiou, Effect of Coenzyme Q10 Supplementation on Statin-Induced Myalgias, The American Journal of Cardiology, vol.110, issue.4
DOI : 10.1016/j.amjcard.2012.04.026

M. S. Brown and . Goldstein, « Multivalent Feedback Regulation of HMG CoA Reductase, a Control Mechanism Coordinating Isoprenoid Synthesis and Cell Growth », Journal of Lipid Research, vol.21, issue.5, pp.505-517, 1980.

. ???, « The LDL Receptor and HMG-CoA Reductase--Two Membrane Molecules That Regulate Cholesterol Homeostasis », Current Topics in Cellular Regulation, vol.26, pp.3-15, 1985.

C. Buettner, B. Roger, . Davis, G. Suzanne, . Leveille et al., Prevalence of Musculoskeletal Pain and Statin Use, Journal of General Internal Medicine, vol.57, issue.4, pp.1182-1186, 2008.
DOI : 10.1007/s11606-008-0636-7

K. F. Buhman, . Accad, and . Farese, Mammalian acyl-CoA:cholesterol acyltransferases, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1529, issue.1-3, pp.142-154
DOI : 10.1016/S1388-1981(00)00144-X

B. E. Burke, R. Neuenschwander, . Olson, and . Randomized, Randomized, Double-Blind, Placebo- Controlled Trial of Coenzyme Q10 in Isolated Systolic Hypertension, Southern Medical Journal, vol.94, issue.11, pp.1112-1117, 2001.
DOI : 10.1097/00007611-200111000-00015

S. Cases, Y. Novak, H. Zheng, S. Myers, . Lear et al., ACAT-2, A Second Mammalian Acyl-CoA:Cholesterol Acyltransferase: ITS CLONING, EXPRESSION, AND CHARACTERIZATION, Journal of Biological Chemistry, vol.273, issue.41, pp.41-26755, 1998.
DOI : 10.1074/jbc.273.41.26755

G. Caso, P. Kelly, A. Margaret, . Mcnurlan, E. William et al., « Effect of Coenzyme q10 on Myopathic Symptoms in Patients Treated with Statins ». The American Journal of Cardiology 99, 2007.

C. C. Chang, . Sakashita, . Ornvold, . Lee, . Chang et al., Immunological Quantitation and Localization of ACAT-1 and ACAT-2 in Human Liver and Small Intestine, The Journal of Biological Chemistry, vol.275, p.36, 2000.

R. K. Chopra, S. Goldman, H. Sinatra, and . Bhagavan, « Relative Bioavailability of Coenzyme Q10 Formulations in Human Subjects Internationale Zeitschrift Für Vitamin- Und Ernährungsforschung, International Journal for Vitamin and Nutrition Research Journal International de Vitaminologie et de Nutrition, vol.68, issue.2, pp.109-113, 1998.

R. Constantinescu, P. Michael, R. Mcdermott, E. A. Dicenzo, C. De-blieck et al., A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q(10) (ubiquinone) », Journal of Clinical Pharmacology, vol.47, pp.12-1580, 2007.

J. M. Cooper, L. Korlipara, P. Hart, J. Bradley, and A. Schapira, « Coenzyme Q10 and Vitamin E Deficiency in Friedreich?s Ataxia: Predictor of Efficacy of Vitamin E and Coenzyme Q10 Therapy, European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, vol.15, issue.12, 2008.

A. Corsini, . Bellosta, . Baetta, . Fumagalli, . Paoletti et al., New insights into the pharmacodynamic and pharmacokinetic properties of statins, New Insights into the Pharmacodynamic and Pharmacokinetic Properties of Statins, pp.413-428, 1999.
DOI : 10.1016/S0163-7258(99)00045-5

F. L. Crane, R. Hatefi, . Lester, and . Widmer, Isolation of a quinone from beef heart mitochondria, Biochimica et Biophysica Acta, vol.25, issue.1, pp.220-221, 1957.
DOI : 10.1016/0006-3002(57)90457-2

D. Pinieux, G. Chariot, F. Ammi-saïd, J. Louarn, . Lejonc et al., Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio, British Journal of Clinical Pharmacology, vol.42, issue.3, pp.333-337, 1996.
DOI : 10.1046/j.1365-2125.1996.04178.x

D. Giovanni, S. Mirabella, . Spinazzola, . Crociani, . Silvestri et al., Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency, Coenzyme Q10 Reverses Pathological Phenotype and Reduces Apoptosis in Familial CoQ10 Deficiency, pp.515-518, 2001.
DOI : 10.1212/WNL.57.3.515

S. Dimmeler, . Aicher, C. Vasa, K. Mildner-rihm, . Adler et al., HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway, HMG-CoA Reductase Inhibitors (statins) Increase Endothelial Progenitor Cells via the PI 3-kinase/Akt Pathway, pp.391-397, 2001.
DOI : 10.1172/JCI200113152

G. Dubuc, A. Chamberland, H. Wassef, J. Davignon, G. Nabil et al., Statins Upregulate PCSK9, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.8, 2004.
DOI : 10.1161/01.ATV.0000134621.14315.43

K. S. Echtay, K. Winkler, . Frischmuth, and . Klingenberg, Uncoupling proteins 2 and 3 are highly active H+ transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone), Proceedings of the National Academy of Sciences of the United States of America 98, 2001.
DOI : 10.1073/pnas.98.4.1416

P. G. Elmberger, E. Kalèn, . Appelkvist, and . Dallner, In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat, European Journal of Biochemistry, vol.115, issue.1, pp.1-11, 1987.
DOI : 10.1016/0014-5793(81)80392-4

A. Endo, . Kuroda, and . Tanzawa, Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity, FEBS Letters, vol.193, issue.2, pp.323-326
DOI : 10.1016/0014-5793(76)80996-9

J. Ericsson, . Thelin, . Chojnacki, and . Dallner, « Substrate Specificity of Cis- Prenyltransferase in Rat Liver Microsomes, The Journal of Biological Chemistry, vol.267, pp.27-19730, 1992.

J. R. Faust, M. Brown, and . Goldstein, « Synthesis of Delta 2-Isopentenyl tRNA from Mevalonate in Cultured Human Fibroblasts, The Journal of Biological Chemistry, vol.25525, pp.14-6546, 1980.

J. Fedacko, D. Pella, P. Fedackova, O. Hänninen, P. Tuomainen et al., « Coenzyme Q(10) and Selenium in Statin-Associated Myopathy Treatment », Canadian Journal of Physiology and Pharmacology, vol.91, issue.2, pp.10-1139, 2013.

O. P. Flint, . Masters, . Gregg, and . Durham, HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell Culture, Toxicology and Applied Pharmacology, vol.145, issue.1, 1997.
DOI : 10.1006/taap.1997.8174

M. Fukami, . Maeda, Y. Fukushige, Y. Kogure, . Shimada et al., Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits, Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie 193, pp.263-273, 1993.
DOI : 10.1007/BF02576234

I. C. Gelissen, M. Harris, K. Rye, C. Quinn, J. Andrew et al., ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.3, 2006.
DOI : 10.1161/01.ATV.0000200082.58536.e1

G. Ghirlanda, . Oradei, . Manto, . Lippa, . Uccioli et al., Evidence of Plasma CoQ10-Lowering Effect by HMG-CoA Reductase Inhibitors: A Double-Blind, Placebo-Controlled Study, The Journal of Clinical Pharmacology, vol.2, issue.3, pp.226-229, 1993.
DOI : 10.1002/j.1552-4604.1993.tb03948.x

S. Giannubilo, L. Raffaele, S. Tiano, F. Cecchi, A. L. Principi et al., Plasma coenzyme Q10 is increased during gestational diabetes, Diabetes Research and Clinical Practice, vol.94, issue.2, 2011.
DOI : 10.1016/j.diabres.2011.07.007

H. N. Ginsberg, N. Le, M. Short, . Ramakrishnan, and . Desnick, Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis., Journal of Clinical Investigation, vol.80, issue.6, pp.1692-1697, 1987.
DOI : 10.1172/JCI113259

J. L. Goldstein and . Brown, Regulation of the mevalonate pathway, Nature, vol.343, issue.6257, 1990.
DOI : 10.1038/343425a0

C. Gómez-díaz, J. Rodríguez-aguilera, M. Barroso, J. Villalba, F. Navarro et al., « Antioxidant Ascorbate Is Stabilized by NADH-Coenzyme Q10 Reductase in the Plasma Membrane, Journal of Bioenergetics and Biomembranes, vol.29, issue.3, pp.251-257, 1997.
DOI : 10.1023/A:1022410127104

S. Greenberg and . Frishman, : A New Drug for Cardiovascular Disease, The Journal of Clinical Pharmacology, vol.7, issue.6, pp.596-608, 1990.
DOI : 10.1002/j.1552-4604.1990.tb01862.x

D. A. Groneberg, B. Kindermann, M. Althammer, M. Klapper, J. Vormann et al., Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells, The International Journal of Biochemistry & Cell Biology, vol.37, issue.6, 2005.
DOI : 10.1016/j.biocel.2004.11.017

S. M. Grundy, Consensus Statement: Role of Therapy With ???Statins??? in Patients With Hypertriglyceridemia, The American Journal of Cardiology, vol.81, issue.4, pp.1-6, 1998.
DOI : 10.1016/S0002-9149(98)00030-7

Z. Guan, . Söderberg, S. Sindelar, . Prusiner, . Kristensson et al., Lipid Composition in Scrapie-Infected Mouse Brain: Prion Infection Increases the Levels of Dolichyl Phosphate and Ubiquinone, Lipid Composition in Scrapie-Infected Mouse Brain: Prion Infection Increases the Levels of Dolichyl Phosphate and Ubiquinone, pp.277-285, 1996.
DOI : 10.1046/j.1471-4159.1996.66010277.x

B. A. Hamelin and . Turgeon, Hydrophilicity/ lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors, Trends in Pharmacological Sciences, vol.19, issue.1, pp.26-37, 1998.
DOI : 10.1016/S0165-6147(97)01147-4

I. P. Hargreaves, A. Lane, M. Patrick, and . Sleiman, « The Coenzyme Q10 Status of the Brain Regions of Parkinson?s Disease Patients », Neuroscience Letters, vol.447, issue.1, 2008.

P. Herpin, G. Lossec, I. Schmidt, F. Cohen-adad, C. Duchamp et al., Effect of age and cold exposure on morphofunctional characteristics of skeletal muscle in neonatal pigs, Effect of Age and Cold Exposure on Morphofunctional Characteristics of Skeletal Muscle in Neonatal Pigs ». Pflügers Archiv, pp.610-618, 2002.
DOI : 10.1007/s00424-002-0867-0

X. Hua, J. Nohturfft, . Goldstein, and . Brown, Sterol Resistance in CHO Cells Traced to Point Mutation in SREBP Cleavage???Activating Protein, Cell, vol.87, issue.3, pp.415-426, 1996.
DOI : 10.1016/S0092-8674(00)81362-8

R. Inoue, M. Tanabe, K. Kono, and K. Maruyama, Ca2+-Releasing Effect of Cerivastatin on the Sarcoplasmic Reticulum of Mouse and Rat Skeletal Muscle Fibers, Journal of Pharmacological Sciences, vol.93, issue.3, pp.279-288, 2003.
DOI : 10.1254/jphs.93.279

V. E. Kagan and Y. Tyurina, Recycling and Redox Cycling of Phenolic Antioxidants, Annals of the New York Academy of Sciences, vol.44, issue.21, pp.425-434, 1998.
DOI : 10.1111/j.1432-1033.1976.tb10588.x

A. Kalén, . Appelkvist, . Chojnacki, and . Dallner, « Nonaprenyl-4-Hydroxybenzoate Transferase, an Enzyme Involved in Ubiquinone Biosynthesis, in the Endoplasmic Reticulum-Golgi System of Rat Liver, The Journal of Biological Chemistry, vol.265, issue.2, pp.15-1158, 1990.

A. Kalén, . Appelkvist, and . Dallner, Age-related changes in the lipid compositions of rat and human tissues, Lipids, vol.262, issue.7, pp.579-584, 1989.
DOI : 10.1007/BF02535072

B. Kaltschmidt, . Sparna, and . Kaltschmidt, B by Reactive Oxygen Intermediates in the Nervous System, Antioxidants & Redox Signaling, vol.1, issue.2, pp.129-144, 1999.
DOI : 10.1089/ars.1999.1.2-129

M. Kamei, . Fujita, . Kanbe, K. Sasaki, . Oshiba et al., « The Distribution and Content of Ubiquinone in Foods Internationale Zeitschrift Für Vitamin-Und Ernährungsforschung, International Journal for Vitamin and Nutrition Research Journal International de Vitaminologie et de Nutrition, vol.56, issue.1, pp.57-63, 1986.

P. Kaufmann, . Török, K. Zahno, . Waldhauser, and . Brecht, « Toxicity of Statins on Rat Skeletal Muscle Mitochondria ». Cellular and Molecular Life Sciences: CMLS 63, pp.2415-2425, 2006.

M. Keith, C. Mazer, . Mikhail, . Jeejeebhoy, . Briet et al., « Coenzyme Q10 in Patients Undergoing CABG: Effect of Statins and Nutritional Supplementation ». Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 18, 2008.

R. K. Keller, Squalene synthase inhibition alters metabolism of nonsterols in rat liver, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1303, issue.3, pp.169-179, 1996.
DOI : 10.1016/0005-2760(96)00081-1

K. Mohammadi, R. , M. Hosseinzadeh-attar, M. Eshraghian, . Nakhjavani et al., « The Effect of Coenzyme Q10 Supplementation on Metabolic Status of Type 2 Diabetic Patients, Minerva Gastroenterologica E Dietologica, vol.59, issue.2, pp.231-236, 2013.

R. Laaksonen, . Jokelainen, . Laakso, . Sahi, M. J. Harkonen et al., The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle, The American Journal of Cardiology, vol.77, issue.10, pp.10-1016, 1996.
DOI : 10.1016/S0002-9149(97)89180-1

. Langsjoen, H. Peter, J. O. Langsjoen, A. M. Langsjoen, A. Lindsay et al., « Treatment of Statin Adverse Effects with Supplemental Coenzyme Q10 and Statin Drug Discontinuation, BioFactors, vol.25, pp.1-4, 2005.

A. G. Lee, How lipids affect the activities of integral membrane proteins, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1666, issue.1-2, 2004.
DOI : 10.1016/j.bbamem.2004.05.012

O. Lee, C. Chang, . Lee, and . Chang, « Immunodepletion Experiments Suggest That Acyl-Coenzyme A:cholesterol Acyltransferase-1 (ACAT-1) Protein Plays a Major Catalytic Role in Adult Human Liver, Adrenal Gland, Macrophages, and Kidney, but Not in Intestines Journal of Lipid Research, vol.39, issue.8, pp.1722-1727, 1998.

P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels, Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation, Physiological Reviews, vol.89, issue.1, 2008.
DOI : 10.1152/physrev.00010.2008

G. Lenaz, C. Fato, M. Castelluccio, C. Genova, . Bovina et al., The function of coenzyme Q in mitochondria, The Clinical Investigator 71, pp.66-70, 1993.
DOI : 10.1007/BF00226843

. Li, G. Zhi-gen, Y. Li, Z. Zhou, J. Chen et al., Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention, Lipids in Health and Disease, vol.12, issue.1, pp.127-137, 2013.
DOI : 10.1016/S0140-6736(00)02502-2

J. K. Liao, Isoprenoids as mediators of the biological effects of statins, Journal of Clinical Investigation, vol.110, issue.3, pp.10-1172, 2002.
DOI : 10.1172/JCI0216421

A. W. Linnane, M. Kios, and L. Vitetta, « Coenzyme Q(10)--Its Role as a Prooxidant in the Formation of Superoxide Anion/hydrogen Peroxide and the Regulation of the Metabolome, 2007.

J. Liu, L. Wang, S. Zhan, . Et-yinyin, and . Xia, « Coenzyme Q10 for Parkinson?s Disease ». The Cochrane Database of Systematic Reviews n o 12, 2011.

P. Löw, C. Andersson, . Edlund, and . Dallner, Effects of mevinolin treatment on tissue dolichol and ubiquinone levels in the rat, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1165, issue.1, pp.102-109, 1992.
DOI : 10.1016/0005-2760(92)90081-6

P. Malchair, . Van-overmeire, . Boland, . Salmon, . Pierard et al., « [Coenzyme Q10: biochemistry, pathophysiology of its deficiency and potential benefit of an increased intake] ». Revue médicale de Liège 60, pp.45-51, 2005.

B. A. Masters, O. Palmoski, . Flint, . Gregg, . Wang-iverson et al., In Vitro Myotoxicity of the 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors, Pravastatin, Lovastatin, and Simvastatin, Using Neonatal Rat Skeletal Myocytes, Toxicology and Applied Pharmacology, vol.131, issue.1, pp.163-174, 1995.
DOI : 10.1006/taap.1995.1058

P. Mattila and J. Kumpulainen, Coenzymes Q9and Q10: Contents in Foods and Dietary Intake, Journal of Food Composition and Analysis, vol.14, issue.4, pp.409-417, 2001.
DOI : 10.1006/jfca.2000.0983

K. N. Maxwell, L. Et-jan, and . Breslow, Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype, Proceedings of the National Academy of Sciences of the United States of America 101
DOI : 10.1073/pnas.0402133101

R. Meganathan, Ubiquinone biosynthesis in microorganisms, FEMS Microbiology Letters, vol.203, issue.2, pp.131-139, 2001.
DOI : 10.1111/j.1574-6968.2001.tb10831.x

M. Mezawa, M. Takemoto, S. Onishi, R. Ishibashi, T. Ishikawa et al., The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study, BioFactors, vol.52, issue.6, 2012.
DOI : 10.1002/biof.1038

P. Mitchell, complex in the respiratory chain: Protonmotive ubiquinone cycle, FEBS Letters, vol.245, issue.1, pp.1-6
DOI : 10.1016/0014-5793(75)80098-6

P. Mohassel, L. Andrew, and . Mammen, Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies, Muscle & Nerve, vol.69, issue.4, 2013.
DOI : 10.1002/mus.23854

D. Mohr, . Bowry, and . Stocker, Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1126, issue.3, pp.247-254, 1992.
DOI : 10.1016/0005-2760(92)90237-P

S. A. Mortensen, « Perspectives on Therapy of Cardiovascular Diseases with Coenzyme Q10 (ubiquinone) ». The Clinical Investigator 71, pp.116-123, 1993.

S. A. Mortensen, E. Leth, . Agner, and . Rohde, Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors, Molecular Aspects of Medicine, vol.18, pp.137-144, 1997.
DOI : 10.1016/S0098-2997(97)00014-9

G. Mundy, . Garrett, . Harris, . Chan, . Chen et al., Stimulation of Bone Formation in Vitro and in Rodents by Statins, Science, vol.286, issue.5446, pp.5446-1946, 1999.
DOI : 10.1126/science.286.5446.1946

P. J. Nestel, H. Elizabeth, . Barnes, M. Andrew, J. Tonkin et al., Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, issue.12, p.12, 2013.
DOI : 10.1161/ATVBAHA.113.302479

G. A. Nichols, E. Et-carol, and . Koro, Does Statin Therapy Initiation Increase the Risk for Myopathy? An Observational Study of 32,225 Diabetic and Nondiabetic Patients, Clinical Therapeutics, vol.29, issue.8, 2007.
DOI : 10.1016/j.clinthera.2007.08.022

M. T. Nunez and . Glass, « Reconstitution of the Transferrin Receptor in Lipid Vesicles, Effect of Cholesterol on the Binding of Transferrin ». Biochemistry, vol.2117, pp.17-4139

S. Ogasahara, D. Engel, . Frens, and . Mack, Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy., Proceedings of the National Academy of Sciences of the United States of America, pp.2379-2382, 1989.
DOI : 10.1073/pnas.86.7.2379

L. Papucci, N. Schiavone, E. Witort, M. Donnini, A. Lapucci et al., Coenzyme Q10 Prevents Apoptosis by Inhibiting Mitochondrial Depolarization Independently of Its Free Radical Scavenging Property, Journal of Biological Chemistry, vol.278, issue.30, 2003.
DOI : 10.1074/jbc.M302297200

J. Pepping and Q. ». Coenzyme, American Journal of Health-System Pharmacy, AJHP: Official Journal of the American Society of Health-System Pharmacists, vol.5615, issue.6, pp.519-521, 1999.

J. A. Porter, . Young, and . Beachy, Cholesterol Modification of Hedgehog Signaling Proteins in Animal Development, Science, vol.274, issue.5285, pp.5285-255, 1996.
DOI : 10.1126/science.274.5285.255

K. A. Radcliffe, W. William, and . Campbell, Statin myopathy, Current Neurology and Neuroscience Reports, vol.99, issue.1, pp.66-72, 2008.
DOI : 10.1007/s11910-008-0011-4

J. J. Repa and . Mangelsdorf, The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis, Annual Review of Cell and Developmental Biology, vol.16, issue.1, 2000.
DOI : 10.1146/annurev.cellbio.16.1.459

T. Róg, M. Pasenkiewicz-gierula, I. Vattulainen, and . Et-mikko-karttunen, « Ordering Effects of Cholesterol and Its Analogues », Biochimica et Biophysica Acta, vol.1788, issue.1, 2009.

E. M. Roth, M. James, C. Mckenney, G. Hanotin, . Asset et al., Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia, New England Journal of Medicine, vol.367, issue.20, pp.1891-1900, 2012.
DOI : 10.1056/NEJMoa1201832

J. Sacher, L. Weigl, M. Werner, C. Szegedi, and M. Hohenegger, Delineation of Myotoxicity Induced by 3-Hydroxy-3-methylglutaryl CoA Reductase Inhibitors in Human Skeletal Muscle Cells, Journal of Pharmacology and Experimental Therapeutics, vol.314, issue.3, 2005.
DOI : 10.1124/jpet.105.086462

M. Safarinejad and . Reza, The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: an open-label prospective study, International Urology and Nephrology, vol.67, issue.3, pp.689-700, 2012.
DOI : 10.1007/s11255-011-0081-0

M. Safarinejad, S. Reza, N. Safarinejad, S. Shafiei, and . Safarinejad, Effects of the Reduced Form of Coenzyme Q10 (Ubiquinol) on Semen Parameters in Men with Idiopathic Infertility: a Double-Blind, Placebo Controlled, Randomized Study, The Journal of Urology, vol.188, issue.2, 2012.
DOI : 10.1016/j.juro.2012.03.131

N. Sakashita, . Miyazaki, . Takeya, C. Horiuchi, T. Chang et al., Localization of Human Acyl-Coenzyme A:Cholesterol Acyltransferase-1 (ACAT-1) in Macrophages and in Various Tissues, The American Journal of Pathology, vol.156, issue.1, pp.227-236, 2000.
DOI : 10.1016/S0002-9440(10)64723-2

C. Santos-ocaña, Q. Thai, S. Do, P. Padilla, . Navas et al., « Uptake of Exogenous Coenzyme Q and Transport to Mitochondria Is Required for bc1 Complex Stability in Yeast Coq Mutants, The Journal of Biological Chemistry, vol.27729, issue.13, 2002.

C. Schmelzer, I. Lindner, C. Vock, K. Fujii, and F. Döring, « Functional Connections and Pathways of Coenzyme Q10-Inducible Genes: An in- Silico Study », IUBMB Life, vol.59, issue.10, 2007.

G. G. Schwartz, G. Anders, M. Olsson, . Abt, M. Christie et al., Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome, New England Journal of Medicine, vol.367, issue.22, pp.22-2089, 2012.
DOI : 10.1056/NEJMoa1206797

V. L. Serebruany, W. Herzog, S. Atamas, P. Gurbel, S. Rohde et al., Hemostatic Changes After Dietary Coenzyme Q10 Supplementation in Swine, Hemostatic Changes after Dietary Coenzyme Q10 Supplementation in Swine, pp.175-181, 1996.
DOI : 10.1097/00005344-199608000-00001

V. L. Serebruany, J. Ordonez, W. Herzog, S. Rohde, K. Mortensen et al., Dietary Coenzyme Q10 Supplementation Alters Platelet Size and Inhibits Human Vitronectin (CD51/CD61) Receptor Expression, Dietary Coenzyme Q10 Supplementation Alters Platelet Size and Inhibits Human Vitronectin (CD51/CD61) Receptor Expression, pp.16-22, 1997.
DOI : 10.1097/00005344-199701000-00003

. Sever, S. Peter, L. Choon, A. K. Chang, A. Gupta et al., The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK, European Heart Journal, vol.32, issue.20, p.20, 2011.
DOI : 10.1093/eurheartj/ehr333

K. A. Sewright, M. Priscilla, . Clarkson, D. Paul, and . Thompson, Statin myopathy: Incidence, risk factors, and pathophysiology, Current Atherosclerosis Reports, vol.144, issue.8A, pp.389-396, 2007.
DOI : 10.1007/s11883-007-0050-3

M. Silva, M. L. Matthews, C. Jarvis, N. M. Nolan, P. Belliveau et al., Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy, Clinical Therapeutics, vol.29, issue.2, 2007.
DOI : 10.1016/j.clinthera.2007.02.008

R. B. Singh, M. Niaz, S. Rastogi, P. Shukla, and . Thakur, Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease, Journal of Human Hypertension, vol.13, issue.3, pp.203-208, 1999.
DOI : 10.1038/sj.jhh.1000778

P. Sirvent, J. Mercier, G. Vassort, and A. Lacampagne, Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle, Biochemical and Biophysical Research Communications, vol.329, issue.3, 2005.
DOI : 10.1016/j.bbrc.2005.02.070

R. Stocker, V. Bowry, and . Frei, Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol., Proceedings of the National Academy of Sciences of the United States of America, pp.1646-1650, 1991.
DOI : 10.1073/pnas.88.5.1646

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC51081

L. Sun, L. Li, L. Joseph, . Goldstein, S. Michael et al., Insig Required for Sterol-mediated Inhibition of Scap/SREBP Binding to COPII Proteins in Vitro, Journal of Biological Chemistry, vol.280, issue.28, 2005.
DOI : 10.1074/jbc.M504041200

M. Svensson, . Malm, . Tonkonogi, . Ekblom, . Sjödin et al., Effect of Q10 Supplementation on Tissue Q10 Levels and Adenine Nucleotide Catabolism During High-Intensity Exercise, International Journal of Sport Nutrition, vol.9, issue.2, pp.166-180, 1999.
DOI : 10.1123/ijsn.9.2.166

I. Tabas, Cholesterol in health and disease, Health and Disease, pp.583-590, 2002.
DOI : 10.1172/JCI0216381

T. Takahashi, . Okamoto, and . Kishi, Characterization of NADPH-Dependent Ubiquinone Reductase Activity in Rat Liver Cytosol: Effect of Various Factors on Ubiquinone-Reducing Activity and Discrimination from Other Quinone Reductases, Journal of Biochemistry, vol.119, issue.2, pp.256-263, 1996.
DOI : 10.1093/oxfordjournals.jbchem.a021232

H. Teclebrhan, . Olsson, . Swiezewska, and . Dallner, « Biosynthesis of the Side Chain of Ubiquinone:trans-Prenyltransferase in Rat Liver Microsomes, The Journal of Biological Chemistry, vol.268, pp.31-23081

A. Thelin, J. Peterson, A. Hutson, J. Mccarthy, . Ericsson et al., Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids, Effect of Squalestatin 1 on the Biosynthesis of the Mevalonate Pathway Lipids, pp.245-249, 1994.
DOI : 10.1016/0005-2760(94)90049-3

A. Thelin, . Schedin, and . Dallner, Half-life of ubiquinone-9 in rat tissues, FEBS Letters, vol.29, issue.2, pp.118-120, 1992.
DOI : 10.1016/0014-5793(92)81425-L

S. R. Thomas, . Neuzil, and . Stocker, Cosupplementation With Coenzyme Q Prevents the Prooxidant Effect of ??-Tocopherol and Increases the Resistance of LDL to Transition Metal??Dependent Oxidation Initiation, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.16, issue.5, pp.687-696, 1996.
DOI : 10.1161/01.ATV.16.5.687

P. D. Thompson, M. Priscilla, . Clarkson, S. Robert, and . Rosenson, et National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel. « An Assessment of Statin Safety by Muscle Experts, The American Journal of Cardiology, vol.97, issue.8A, 2006.

M. Tomasetti, . Alleva, . Borghi, and . Collins, In vivo supplementation with coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage, The FASEB Journal, vol.15, issue.8, pp.1425-1427, 2001.
DOI : 10.1096/fj.00-0694fje

M. Tomasetti, G. Littarru, . Stocker, and . Alleva, Coenzyme Q10 enrichment decreases oxidative DNA damage in human lymphocytes, Free Radical Biology and Medicine, vol.27, issue.9-10, pp.9-10, 1999.
DOI : 10.1016/S0891-5849(99)00132-X

Y. Tomono, . Hasegawa, . Seki, . Motegi, and . Morishita, « Pharmacokinetic Study of Deuterium-Labelled Coenzyme Q10 in Man, International Journal of Clinical Pharmacology, Therapy, and Toxicology, vol.24, pp.10-536, 1986.

. Tran, C. Uyenphuong, F. Et-catherine, and . Clarke, Endogenous synthesis of coenzyme Q in eukaryotes, Mitochondrion, vol.7, issue.7
DOI : 10.1016/j.mito.2007.03.007

M. Turunen, J. Peters, F. J. Gonzalez, S. Schedin, and . Dallner, « Influence of Peroxisome Proliferator-Activated Receptor Alpha on Ubiquinone Biosynthesis », Journal of Molecular Biology, vol.297, issue.3, 2000.

M. Turunen, J. Olsson, and G. Dallner, Metabolism and function of coenzyme Q, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1660, issue.1-2, pp.171-199, 2004.
DOI : 10.1016/j.bbamem.2003.11.012

M. Turunen, L. Wehlin, M. Sjöberg, J. Lundahl, G. Dallner et al., ??2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10, Biochemical and Biophysical Research Communications, vol.296, issue.2, pp.255-260, 2002.
DOI : 10.1016/S0006-291X(02)00871-9

S. Vadhanavikit and H. Ganther, Decreased Ubiquinone Levels in Tissues of Rats Deficient in Selenium, Biochemical and Biophysical Research Communications, vol.190, issue.3, 1993.
DOI : 10.1006/bbrc.1993.1137

M. Vidyarthi, P. Jacob, A. Et-tahseen, and . Chowdhury, « Oral Use of ?Low and Slow? Rosuvastatin with Co-Enzyme Q10 in Patients with Statin-Induced Myalgia: Retrospective Case Review, Indian Journal of Endocrinology and Metabolism, vol.16, issue.2, 2012.

J. M. Villalba, . Navarro, . Córdoba, . Serrano, F. Arroyo et al., Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport., Proceedings of the National Academy of Sciences of the United States of America 92, pp.4887-4891, 1995.
DOI : 10.1073/pnas.92.11.4887

. Vladutiu, D. Georgirene, Z. Simmons, J. Paul, M. Isackson et al., Genetic risk factors associated with lipid-lowering drug-induced myopathies, Muscle & Nerve, vol.37, issue.2, 2006.
DOI : 10.1002/mus.20567

X. Wang, . Li, L. David, . Rainwater, C. Michael et al., « Cosupplementation with Vitamin E and Coenzyme Q10 Reduces Circulating Markers of Inflammation in Baboons, The American Journal of Clinical Nutrition, vol.80, issue.3, pp.649-655, 2004.

G. J. Warner, M. Berry, . Moustafa, D. Carlson, . Hatfield et al., Inhibition of Selenoprotein Synthesis by Selenocysteine tRNA super[Ser]Sec Lacking Isopentenyladenosine, Journal of Biological Chemistry, vol.275, issue.36, 2000.
DOI : 10.1074/jbc.M001280200

K. A. Weant, M. Kelly, and . Smith, « The Role of Coenzyme Q10 in Heart Failure ». The Annals of Pharmacotherapy 39, 2005.

G. Weitz-schmidt, . Welzenbach, . Brinkmann, . Kamata, C. Kallen et al., « Statins Selectively Inhibit Leukocyte Function Antigen-1 by Binding to a Novel Regulatory Integrin Site », Nature Medicine, vol.7, issue.6, pp.687-692, 2001.
DOI : 10.1038/89058

C. White and . Michael, A Review of the Pharmacologic and Pharmacokinetic Aspects of Rosuvastatin, Journal of Clinical Pharmacology, vol.42, issue.9, pp.963-970, 2002.
DOI : 10.1177/0091270002042009002

M. Wyman, M. Leonard, and T. Morledge, Coenzyme Q10: A therapy for hypertension and statin-induced myalgia?, Cleveland Clinic Journal of Medicine, vol.77, issue.7, 2010.
DOI : 10.3949/ccjm.77a.09078

L. Xia, T. Nordman, M. Jerker, A. Olsson, L. Damdimopoulos et al., The Mammalian Cytosolic Selenoenzyme Thioredoxin Reductase Reduces Ubiquinone. A NOVEL MECHANISM FOR DEFENSE AGAINST OXIDATIVE STRESS, Journal of Biological Chemistry, vol.278, issue.4, 2003.
DOI : 10.1074/jbc.M210456200

A. Yamamoto, . Sudo, and . Endo, Therapeutic effects of ML-236B in primary hypercholesterolemia, Atherosclerosis, vol.35, issue.3, pp.259-266, 1980.
DOI : 10.1016/0021-9150(80)90124-0

Y. Yamamoto and . Yamashita, Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress, Molecular Aspects of Medicine, vol.18, pp.79-84, 1997.
DOI : 10.1016/S0098-2997(97)00007-1

Y. Yamamoto, . Yamashita, . Fujisawa, . Kokura, and . Yoshikawa, Oxidative Stress in Patients with Hepatitis, Cirrhosis, and Hepatoma Evaluated by Plasma Antioxidants, Biochemical and Biophysical Research Communications, vol.247, issue.1, 1998.
DOI : 10.1006/bbrc.1998.8752

Y. Yamauchi, C. C. Chang, M. Hayashi, S. Abe-dohmae, C. Patrick et al., Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts, The Journal of Lipid Research, vol.45, issue.10, pp.400264-200, 2004.
DOI : 10.1194/jlr.M400264-JLR200

P. L. Yeagle, Cholesterol and the cell membrane, Cholesterol and the Cell Membrane, pp.267-287, 1985.
DOI : 10.1016/0304-4157(85)90011-5

T. Ylikoski, . Piirainen, . Hanninen, and . Penttinen, The effect of coenzyme Q10 on the exercise performance of cross-country skiers, Molecular Aspects of Medicine, vol.18, pp.283-290, 1997.
DOI : 10.1016/S0098-2997(97)00038-1

J. Yu, K. Sewright, J. Monica, J. Hubal, . Liu et al., Investigation of gene Expression in C2C12 Myotubes Following simvastatin Application and Mechanical Strain, Journal of Atherosclerosis and Thrombosis, vol.16, issue.1, pp.21-29, 2009.
DOI : 10.5551/jat.E551

Y. Zhang, E. Appelkvist, . Kristensson, and . Dallner, The lipid compositions of different regions of rat brain during development and aging, Neurobiology of Aging, vol.17, issue.6, pp.869-875, 1996.
DOI : 10.1016/S0197-4580(96)00076-0